Search alternatives:
values increased » cases increased (Expand Search), also increased (Expand Search), rate increased (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
c values » ct values (Expand Search), _ values (Expand Search), i values (Expand Search)
b large » _ large (Expand Search), i large (Expand Search), _ larger (Expand Search)
a large » _ large (Expand Search)
values increased » cases increased (Expand Search), also increased (Expand Search), rate increased (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
c values » ct values (Expand Search), _ values (Expand Search), i values (Expand Search)
b large » _ large (Expand Search), i large (Expand Search), _ larger (Expand Search)
a large » _ large (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
Supplementary Material for: Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
Published 2021“…<b><i>Introduction:</i></b> The chemoresistance mechanism of diffuse large B-cell lymphoma (DLBCL) is still poorly understood, and patient prognosis remains unsatisfactory. …”
-
152
-
153
Table1_Multi-Scale Modeling Recapitulates the Effect of Genetic Alterations Associated With Diffuse Large B-Cell Lymphoma in the Germinal Center Dynamics.docx
Published 2022“…Several transcription factors and signaling pathways that play a central role in the progression of the GC reaction and B-cell differentiation have been shown to play an oncogenic role in diffuse large B-cell lymphoma. …”
-
154
DataSheet_1_A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma.docx
Published 2024“…Background<p>Approximately one-third of patients with diffuse large B-cell lymphoma (DLBCL) are refractory to treatment or experience relapse after initial therapy. …”
-
155
DataSheet_1_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.xlsx
Published 2022“…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
-
156
DataSheet_2_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.docx
Published 2022“…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …”
-
157
DataSheet_1_Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.xlsx
Published 2022“…<p>The relationship between rheumatoid arthritis (RA) and diffuse large B-cell lymphoma (DLBCL) is well characterized, but the molecular mechanisms underlying this association have not been clearly investigated. …”
-
158
-
159
-
160